PMX-30063 The First And Only Defensin Mimetic Systemic Antibiotic Drug In Human Clinical Trials - Tidingo.com

PMX-30063 The First And Only Defensin Mimetic Systemic Antibiotic Drug In Human Clinical Trials

Link:

PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has initiated dosing and commenced a Phase I clinical study in Canada for its defensin mimetic antibiotic compound, PMX-30063.

PMX-30063 The First And Only Defensin Mimetic Systemic Antibiotic Drug In Human Clinical Trials - témata

The, First, And, Only, Defensin, Mimetic, Systemic, Antibiotic, Drug, Human, Clinical, Trials, PMX-30063 The First And Only Defensin Mimetic Systemic Antibiotic Drug, Human Clinical Trials , Inc, (OTC, BB:, PYMX), Phase, Canada, PMX-30063, PolyMedix, Inc. (OTC BB: PYMX),, PMX-30063 The First And Only Defensin Mimetic Systemic Antibiotic Drug In Human Clinical Trials,

RSS sources

Your own sources

Your own RSS you can add after registration

Public sources


Create an account Password
© 2005-2008  
RSS Sources list
Wallpapers | RSS čtečka | Webové stránky | Sportovní hry | Webhry | Texty písní | Závody | Dětské hry | Repliky zbraní | TIXIK.com | Mapy | Pattaya Hotels | Honeymoon Planning | Torent download | Parfémy | Sydney | Москва | Bitky.net | Pocitacove-hry.net | Obrazky-tapety.com | Muži | Celebrity | České celebrity | Bulvár | Soutěže o ceny | Finance | Cestování | MP3 | Kalendář online, svátky | SEO | Svářečky CO2 | Chovatelské potřeby | New York |
Loading messages